The identification of new drugs exhibiting reduced adverse side-effects constitutes a great challenge for the next decade. Various steps are needed to screen for good ligand candidates and one of them is the evaluation of their binding properties. New strategies based on fluorescence measurement constitute excellent alternatives to the traditional radioactive assays. Less hazardous, faster and cheaper, these methods also exhibit very good sensitivity and can be used on various biological models such as heterologous expression systems or native tissues.
References
[1]
Overington, J.P.; Al-Lazikani, B.; Hopkins, A.L. How many drug targets are there? Nat. Rev. Drug Discov.？2006, 5, 993–996, doi:10.1038/nrd2199. 17139284
[2]
Galandrin, S.; Oligny-Longpre, G.; Bouvier, M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci.？2007, 28, 423–430, doi:10.1016/j.tips.2007.06.005. 17659355
[3]
Terrillon, S.; Bouvier, M. Roles of G-protein-coupled receptor dimerization. EMBO Rep.？2004, 5, 30–34, doi:10.1038/sj.embor.7400052. 14710183
[4]
Milligan, G. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol.？2004, 66, 1–7, doi:10.1124/mol.104.000497. 15213289
[5]
Handl, H.L.; Vagner, J.; Yamamura, H.I.; Hruby, V.J.; Gillies, R.J. Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor. Anal. Biochem.？2005, 343, 299–307, doi:10.1016/j.ab.2005.05.040. 16004955
[6]
Parker, G.J.; Law, T.L.; Lenoch, F.J.; Bolger, R.E. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J. Biomol. Screen.？2000, 5, 77–88, doi:10.1177/108705710000500204. 10803607
[7]
Owicki, J.C. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J. Biomol. Screen.？2000, 5, 297–306, doi:10.1177/108705710000500501. 11080688
[8]
Allen, M.; Reeves, J.; Mellor, G. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors. J. Biomol. Screen.？2000, 5, 63–69, doi:10.1177/108705710000500202. 10803605
[9]
Abel, A.; Wittau, N.; Wieland, T.; Schultz, G.; Kalkbrenner, F. Cell cycle-dependent coupling of the vasopressin V1a receptor to different G proteins. J. Biol. Chem.？2000, 275, 32543–32551, doi:10.1074/jbc.M002171200. 10931825
[10]
Albers, H.E.; Karom, M.; Smith, D. Serotonin and vasopressin interact in the hypothalamus to control communicative behavior. Neuroreport？2002, 13, 931–933, doi:10.1097/00001756-200205240-00006. 12004193
[11]
Gagne, A.; Banks, P.; Hurt, S.D. Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors. J. Recept. Signal Transduct. Res.？2002, 22, 333–343, doi:10.1081/RRS-120014605. 12503625
[12]
Albizu, L.; Teppaz, G.; Seyer, R.; Bazin, H.; Ansanay, H.; Manning, M.; Mouillac, B.; Durroux, T. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands. J. Med. Chem.？2007, 50, 4976–4985, doi:10.1021/jm061404q. 17850055
Chalfie, M.; Tu, Y.; Euskirchen, G.; Ward, W.W.; Prasher, D.C. Green fluorescent protein as a marker for gene expression. Science？1994, 263, 802–805, doi:10.1126/science.8303295. 8303295
[15]
Bonnet, D.; Ilien, B.; Galzi, J.L.; Riche, S.; Antheaune, C.; Hibert, M. A rapid and versatile method to label receptor ligands using “click” chemistry: Validation with the muscarinic M1 antagonist pirenzepine. Bioconjug. Chem.？2006, 17, 1618–1623, doi:10.1021/bc060140j. 17105244
[16]
Ilien, B.; Franchet, C.; Bernard, P.; Morisset, S.; Weill, C.O.; Bourguignon, J.J.; Hibert, M.; Galzi, J.L. Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. J. Neurochem.？2003, 85, 768–778, doi:10.1046/j.1471-4159.2003.01717.x. 12694403
[17]
Tahtaoui, C.; Guillier, F.; Klotz, P.; Galzi, J.L.; Hibert, M.; Ilien, B. On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies. J. Med. Chem.？2005, 48, 7847–7859, doi:10.1021/jm050459+. 16302823
[18]
Bazin, H.; Trinquet, E.; Mathis, G. Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. J. Biotechnol.？2002, 82, 233–250. 11999692
[19]
Selvin, P.R. Principles and biophysical applications of lanthanide-based probes. Annu. Rev. Biophys. Biomol. Struct.？2002, 31, 275–302, doi:10.1146/annurev.biophys.31.101101.140927. 11988471
[20]
Maurel, D.; Kniazeff, J.; Mathis, G.; Trinquet, E.; Pin, J.P.; Ansanay, H. Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. Anal. Biochem.？2004, 329, 253–262, doi:10.1016/j.ab.2004.02.013. 15158484
[21]
Gronemeyer, T.; Chidley, C.; Juillerat, A.; Heinis, C.; Johnsson, K. Directed evolution of O6-alkylguanine-DNA alkyltransferase for applications in protein labeling. Protein Eng. Des. Sel.？2006, 19, 309–316, doi:10.1093/protein/gzl014. 16638797
[22]
Juillerat, A.; Gronemeyer, T.; Keppler, A.; Gendreizig, S.; Pick, H.; Vogel, H.; Johnsson, K. Directed evolution of O6-alkylguanine-DNA alkyltransferase for efficient labeling of fusion proteins with small molecule in vivo. Chem. Biol.？2003, 10, 313–317, doi:10.1016/S1074-5521(03)00068-1. 12725859
[23]
Juillerat, A.; Heinis, C.; Sielaff, I.; Barnikow, J.; Jaccard, H.; Kunz, B.; Terskikh, A.; Johnsson, K. Engineering substrate specificity of O6-alkylguanine-DNA alkyltransferase for specific protein labeling in living cells. ChemBioChem？2005, 6, 1263–1269, doi:10.1002/cbic.200400431. 15934048
[24]
Keppler, A.; Gendreizig, S.; Gronemeyer, T.; Pick, H.; Vogel, H.; Johnsson, K. A general method for the covalent labeling of fusion proteins with small molecule in vivo. Nat. Biotechnol.？2003, 21, 86–89, doi:10.1038/nbt765. 12469133
[25]
Keppler, A.; Pick, H.; Arrivoli, C.; Vogel, H.; Johnsson, K. Labeling of fusion proteins with synthetic fluorophores in live cells. Proc. Natl. Acad. Sci. USA？2004, 101, 9955–9959, doi:10.1073/pnas.0401923101. 15226507
Zwier, J.M.; Roux, T.; Cottet, M.; Durroux, T.; Douzon, S.; Bdioui, S.; Gregor, N.; Bourrier, E.; Oueslati, N.; Nicolas, L.; Tinel, N.; Boisseau, C.; Yverneau, P.; Charrier-Savournin, F.; Fink, M.; Trinquet, E. A fluorescent ligand-binding alternative using tag-lite(R) technology. J. Biomol. Screen.？2010, 15, 1248–1259, doi:10.1177/1087057110384611. 20974902
[28]
George, N.; Pick, H.; Vogel, H.; Johnsson, N.; Johnsson, K. Specific labeling of cell surface proteins with chemically diverse compounds. J. Am. Chem. Soc.？2004, 126, 8896–8897, doi:10.1021/ja048396s. 15264811
[29]
Meyer, B.H.; Segura, J.M.; Martinez, K.L.; Hovius, R.; George, N.; Johnsson, K.; Vogel, H. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc. Natl. Acad. Sci. USA？2006, 103, 2138–2143, doi:10.1073/pnas.0507686103. 16461466
